Suchergebnisse - "Barlesi, F"

PubPharm (258)

11

Final results of the IFCT-0803 study, a phase II study of cetuximab, pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non-squamous, non-small-cell lung cancer

enthalten in: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique | 2022

von Trédaniel, J. | Barlési, F. | Le Péchoux, C. | +19

12

Access to early-phase clinical trials in older patients with cancer in France : the EGALICAN-2 study

enthalten in: ESMO open | 2022

von Baldini, C. | Charton, E. | Schultz, E. | +19

13

Treatment with a retinoic acid-inducible gene I (RIG-I) agonist as monotherapy and in combination with pembrolizumab in patients with advanced solid tumors: results from two phase 1 studies

enthalten in: Cancer immunology immunotherapy | 2022

von Moreno, V. | Calvo, E. | Middleton, M. | +11

14

Treatment with a retinoic acid-inducible gene I (RIG-I) agonist as monotherapy and in combination with pembrolizumab in patients with advanced solid tumors: results from two phase 1 studies

enthalten in: Cancer immunology immunotherapy | 2022

von Moreno, V. | Calvo, E. | Middleton, M. | +11

15

Treatment with a retinoic acid-inducible gene I (RIG-I) agonist as monotherapy and in combination with pembrolizumab in patients with advanced solid tumors: results from two phase 1 studies

enthalten in: Cancer immunology immunotherapy | 2022

von Moreno, V. | Calvo, E. | Middleton, M. | +11

16

Single-cell DNA-seq depicts clonal evolution of multiple driver alterations in osimertinib-resistant patients

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2022

von Chen, J. | Facchinetti, F. | Braye, F. | +19

17

Postgraduate oncology educational shifts during the COVID-19 pandemic : results of faculty and medical student surveys

enthalten in: ESMO open | 2022

von Moya-Plana, A. | Tselikas, L. | Lambotte, O. | +6

18

IFCT-1502 CLINIVO : real-world evidence of long-term survival with nivolumab in a nationwide cohort of patients with advanced non-small-cell lung cancer

enthalten in: ESMO open | 2022

von Molinier, O. | Besse, B. | Barlesi, F. | +18

19

Manufacture of adoptive cell therapies at academic cancer centers : scientific, safety and regulatory challenges

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2022

von Saini, K. | Svane, I. | Juan, M. | +2

20

Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy - results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2022

von Peters, S. | Pujol, J. | Dafni, U. | +116